Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.19 USD | +5.84% | +0.15% | +7.83% |
Financials (USD)
Sales 2024 * | 583M | Sales 2025 * | 597M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2024 * | 125M | Net income 2025 * | 154M | EV / Sales 2024 * | 2.11 x |
Net Debt 2024 * | 146M | Net cash position 2025 * | 194M | EV / Sales 2025 * | 1.49 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
8.49
x | Employees | 197 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.55% |
Latest transcript on Collegium Pharmaceutical, Inc.
1 day | +5.84% | ||
1 week | +0.15% | ||
Current month | +0.15% | ||
1 month | -11.02% | ||
3 months | -10.78% | ||
6 months | +22.11% | ||
Current year | +7.83% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 01-12-31 | |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 67 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 28 M€ | -3.53% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 33.19 | +5.84% | 861,068 |
24-06-06 | 31.36 | -1.10% | 297,983 |
24-06-05 | 31.71 | +0.86% | 522,371 |
24-06-04 | 31.44 | -2.57% | 611,578 |
24-06-03 | 32.27 | -2.63% | 516,142 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.83% | 1.09B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- COLL Stock